-
Tariffs set to hit Ireland, where US drugmakers play tax games
19 Aug 2025 09:09 GMT
… of cancer medications, weight-loss drug ingredients and other pharmaceutical products … of cancer medications, weight-loss drug ingredients and other pharmaceutical products … lower their overall tax bill.
Forest Laboratories, now owned by AbbVie, shifted …
-
P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease
04 Jun 2025 22:32 GMT
COI Statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the the Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Switzerland and …
-
Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight
11 Sep 2025 17:00 GMT
… 25+ pipeline bipolar disorder drugs.
Key bipolar disorder companies … MDD companies, including Takeda Pharmaceuticals, Forest Laboratories, Otsuka Pharmaceuticals, Janssen Research … specific market trends, in emerging drugs, and competitive strategies. These …
-
Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med
07 Jul 2024 22:44 GMT
… makes Sanofi and Regeneron Pharmaceuticals drug Dupixent the first biologic … his career, Rowe worked at Forest Laboratories, which developed roflumilast, approved by … require hospitalization. Results showed the drug, administered as a subcutaneous injection …
-
Global Angina Pectoris Treatment Market Report 2022 to 2030 - Featuring Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Novartis and Pfizer Among Others - ResearchAndMarkets.com
31 Jan 2023 14:56 GMT
… pipeline analysis of upcoming potential drugs.
Companies Profiled
Abbott Laboratories Inc … F. Hoffmann-La Roche Ltd.
Forest Laboratories Inc.
Gilead Sciences, Inc.
GlaxoSmithKline … pectoris treatment market comprises potential drugs which are specific and fast …
-
Global Substance Abuse Treatment Market Report to 2030 - Featuring Alkermes, Allergan, Forest Laboratories and GlaxoSmithKline Among Others
30 Jan 2023 10:25 GMT
… market segments based on drug class and different geographical … use of habit forming drugs or substances; leading to … rise in the number of drug addicted population, increased government … 4. Strategic Initiatives
10.3. Forest Laboratories, Inc.
10.3.1. …
-
Second Circuit dismisses suit against drugmaker that paid competitors to delay generic release
13 May 2024 21:45 GMT
… previous federal court wins for Forest Laboratories.
CVS Pharmacy, Rite Aid and … the market release of the drug.
Forest Laboratories' competitors, including Hetero, Torrent, … for a billion-dollar blockbuster drug was nefarious,” the panel said.
“ …
-
Dementia Drugs Market to See Booming Growth 2024-2031 | Novartis AG, Sanofi S.A, Eisai, Inc, Janssen Pharmaceuticals,Inc
01 Apr 2024 09:40 GMT
… Drugs Market:
◘ Eisai Inc.
◘ Janssen Pharmaceuticals Inc.
◘ Biogen Pharmaceuticals
◘ Forest Laboratories … :
Global Dementia Drugs Market, By Drug Class:
MAO Inhibitors … Validation and Credibility: Dementia Drugs Market research reports offer …
-
Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region - ResearchAndMarkets.com
08 Feb 2024 12:44 GMT
… undergoing antidepressant therapy.
By drug class, antidepressants was the … players, increasing demand for antidepressant drugs, rising research & development … 's Laboratory
Sanofi-Aventis
Forest Laboratories
Segmentation: Anxiety Disorders And …
-
Tonix closes in on the first new fibromyalgia drug in more than a decade
29 Jan 2024 15:11 GMT
… and Forest Laboratories’ Savella between 2007 and 2009. But these drugs … sites, found that the drug, helped relieve fibromyalgia symptoms … three decades.
Importantly, the drug doesn’t target fibromyalgia … and women taking the drug said their sexual function …
About
© 1995-2025